Irene M. Lang
- Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertensionBy Gérald Simonneau, Adam Torbicki, Marius M. Hoeper, Marion Delcroix, Kristóf Karlócai, Nazzareno Galiè, Bruno Degano, Diana Bonderman, Marcin Kurzyna, Michela Efficace, Ruben Giorgino and Irene M. LangGérald Simonneau*AP-HP Hôpital Antoine Béclère, Dept of Pneumology, Clamart, FranceAdam Torbicki#Dept of Pulmonary Circulation and Thromboembolic Diseases, Postgraduate Medical School, ECZ-Otwock, Warsaw, PolandMarius M. Hoeper¶Hannover Medical School, Hannover, GermanyMarion Delcroix+University Hospitals (UZ) Leuven, Leuven, BelgiumKristóf Karlócai§Semmelweis University, Budapest, HungaryNazzareno GalièfUniversity of Bologna, Institute of Cardiology, Bologna, ItalyBruno Degano*AP-HP Hôpital Antoine Béclère, Dept of Pneumology, Clamart, FranceDiana Bonderman**Medical University of Vienna, Dept of Internal Medicine II, Division of Cardiology, Vienna, AustriaMarcin Kurzyna#Dept of Pulmonary Circulation and Thromboembolic Diseases, Postgraduate Medical School, ECZ-Otwock, Warsaw, PolandMichela Efficace##Actelion Pharmaceuticals Ltd, Allschwil, SwitzerlandRuben Giorgino##Actelion Pharmaceuticals Ltd, Allschwil, SwitzerlandIrene M. Lang**Medical University of Vienna, Dept of Internal Medicine II, Division of Cardiology, Vienna, Austria
- Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understandingBy Irene M. Lang, Raffaele Pesavento, Diana Bonderman and Jason X-J. YuanIrene M. Lang*Dept of Internal Medicine II, Division of Cardiology, Vienna General Hospital, Medical University of Vienna, Vienna, AustriaRaffaele Pesavento#Dept of Cardiothoracic and Vascular Sciences, University of Padua, Padua, ItalyDiana Bonderman*Dept of Internal Medicine II, Division of Cardiology, Vienna General Hospital, Medical University of Vienna, Vienna, AustriaJason X-J. Yuan¶Dept of Medicine, University of Illinois at Chicago, Chicago, IL, USA
- Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertensionBy Magdalena Sophie Strobl, Catharina Schreiber, Stefan Hubmer, Helga Bergmeister, Irene M. Lang and Diana BondermanMagdalena Sophie Strobl1Department of Internal Medicine II, Division of Cardiology, Medical University Vienna, AustriaCatharina Schreiber1Department of Internal Medicine II, Division of Cardiology, Medical University Vienna, AustriaStefan Hubmer1Department of Internal Medicine II, Division of Cardiology, Medical University Vienna, AustriaHelga Bergmeister1Department of Internal Medicine II, Division of Cardiology, Medical University Vienna, AustriaIrene M. Lang1Department of Internal Medicine II, Division of Cardiology, Medical University Vienna, AustriaDiana Bonderman1Department of Internal Medicine II, Division of Cardiology, Medical University Vienna, Austria
- Angiogenesis in chronic thromboembolic pulmonary hypertension (CTEPH)By Sherin Puthenkalam, Adelheid Panzenboeck, Uwe Schubert, Johannes Jakowitsch, Klaus T. Preissner, Robert Voswinckel, Walter Klepetko and Irene M. LangSherin Puthenkalam1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, AustriaAdelheid Panzenboeck1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, AustriaUwe Schubert2Medical School, Institute for Biochemistry, Justus Liebig University, Giessen, GermanyJohannes Jakowitsch1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, AustriaKlaus T. Preissner2Medical School, Institute for Biochemistry, Justus Liebig University, Giessen, GermanyRobert Voswinckel3Department of Lung Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, GermanyWalter Klepetko4Department of Surgery, Division of Cardiothoracic Surgery, Medical University of Vienna, AustriaIrene M. Lang1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria
- Risk factors and basic mechanisms of CTEPH – a current understandingBy Irene M. Lang, Raffaele Pesavento, Diana Bonderman and Jason X.-J. YuanArticle | Published in 2012 in European Respiratory JournalIrene M. LangRaffaele PesaventoDiana Bonderman
- Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patientsBy Diana Zabini, Akos Heinemann, Vasile Foris, Chandran Nagaraj, Patrick Nierlich, Zoltán Bálint, Grazyna Kwapiszewska, Irene M. Lang, Walter Klepetko, Horst Olschewski and Andrea OlschewskiArticle | Published in 2014 in European Respiratory JournalDiana Zabini1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaAkos Heinemann2Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, AustriaVasile Foris1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaChandran Nagaraj1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaPatrick Nierlich3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaZoltán Bálint1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaGrazyna Kwapiszewska1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, AustriaIrene M. Lang5Dept of Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, AustriaWalter Klepetko3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaHorst Olschewski6Dept of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, AustriaAndrea Olschewski1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, Austria
- Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patientsBy Diana Zabini, Akos Heinemann, Vasile Foris, Chandran Nagaraj, Patrick Nierlich, Zoltán Bálint, Grazyna Kwapiszewska, Irene M. Lang, Walter Klepetko, Horst Olschewski and Andrea OlschewskiDiana Zabini1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaAkos Heinemann2Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, AustriaVasile Foris1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaChandran Nagaraj1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaPatrick Nierlich3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaZoltán Bálint1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaGrazyna Kwapiszewska1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, AustriaIrene M. Lang5Dept of Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, AustriaWalter Klepetko3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaHorst Olschewski6Dept of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, AustriaAndrea Olschewski1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, Austria
- Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertensionBy Irene M. Lang and Sean P. GaineIrene M. Lang1Division of Cardiology, Medical University of Vienna, Vienna, AustriaSean P. Gaine2National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland
- How to define pulmonary hypertension due to left heart diseaseBy Mario Gerges, Christian Gerges and Irene M. LangArticle | Published in 2016 in European Respiratory JournalMario GergesDept of Internal Medicine II, Division of Cardiology, Vienna General Hospital, Medical University of Vienna, Vienna, AustriaChristian GergesDept of Internal Medicine II, Division of Cardiology, Vienna General Hospital, Medical University of Vienna, Vienna, AustriaIrene M. LangDept of Internal Medicine II, Division of Cardiology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.